[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 309
Citations 0
Comment & Response
July 1, 2020

Questions on a Randomized Clinical Trial of Stellate Ganglion Block for Patients With Posttraumatic Stress Disorder

Author Affiliations
  • 1VA San Diego Healthcare System, San Diego, California
  • 2Department of Psychiatry, University of California San Diego
  • 3Department of Family Medicine and Public Health, University of California San Diego
  • 4Altman Clinical and Translational Research Institute, University of California San Diego
JAMA Psychiatry. Published online July 1, 2020. doi:10.1001/jamapsychiatry.2020.1815

To the Editor The randomized clinical trial by Rae Olmsted et al1 on stellate ganglion block for patients with posttraumatic stress disorder (PTSD) may have major treatment implications. In comparing elements of the article with specifications in ClinicalTrials.gov,2 I noted some discrepancies that merit discussion.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words